Market Signal Briefing

Dogecoin briefly rallied more than 4% to reach $0.156, but late-session selling quickly erased most of its momentum as broader crypto markets reacted to Bitcoin’s newly triggered Death Cross. The crossover—where BTC’s 50-day moving average slid beneath the 200-day moving average for the first time since 2022—sparked fresh concerns across risk-on assets and pushed sentiment deep into Extreme Fear. With Bitcoin dropping below $94,000 and ETF outflows accelerating, liquidity across the meme-coin sector tightened sharply, placing additional pressure on DOGE just as bullish traders attempted to build a breakout structure.

Despite the turbulent backdrop, Dogecoin showed early strength. Buyers stepped in aggressively around the $0.155–$0.158 support zone, defending the level with volume nearly 30% above weekly norms. DOGE briefly broke above $0.164 during intraday trade, a sign that institutional players may have been accumulating beneath market price as 1.26 billion DOGE exchanged hands. This heavy bid activity helped stabilize the chart and pushed the token into an ascending structure that hinted at a potential continuation move.

However, the market tone shifted as Bitcoin extended its decline and algorithmic selling rippled through altcoins. The final hour of trading brought a decisive wave of profit-taking, pulling DOGE down 2.5% and breaking its last higher-low pattern. This reversal underscored how closely Dogecoin remains correlated with Bitcoin’s macro trend—particularly during periods of liquidity contraction, when meme coins historically underperform.

Heading into the week, traders are watching whether Dogecoin can hold the critical $0.158 level. Sustained accumulation here would suggest whales are absorbing the macro-driven sell pressure. A daily close below it, however, exposes DOGE to a fast move toward $0.152 or even $0.148 as trading depth thins. To regain bullish momentum, the token must reclaim $0.160 and push decisively through the $0.163–$0.165 resistance zone.

Market participants should also monitor volume, as spikes above 1 billion DOGE often align with trend continuation. Ultimately, Bitcoin’s ability to stabilize above $93,000—and whether ETF outflows slow—will dictate short-term volatility across the entire meme-coin landscape, keeping DOGE firmly tied to macro sentiment in the days ahead.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Grayscale is moving steadily closer to launching its long-awaited Dogecoin ETF, signaling what could soon become the second DOGE-focused exchange-traded product available in the United States. The firm’s effort highlights the growing competition among issuers and the different regulatory strategies being used to bring crypto-based funds to market.

Bloomberg ETF analyst Eric Balchunas recently suggested that Grayscale may debut its Dogecoin ETF as early as November 24, noting that the company’s ongoing transition of its crypto trusts into ETFs mirrors the approach taken with its other digital-asset products. While the SEC has not provided any official timeline, industry watchers are paying close attention as Grayscale pushes forward.

The company began the conversion process on August 15, 2025, by filing an S-1 registration statement for the Grayscale Dogecoin Trust. The goal is to list the ETF under the ticker GDOG. Grayscale later submitted a 19b-4 application with NYSE Arca on January 31, seeking approval to list the fund for public trading. Both filings fall under the Securities Act of 1933, meaning GDOG cannot go live until the SEC grants direct approval.

This path stands in contrast to the strategy used by REX-Osprey, which brought the first Dogecoin ETF—DOJE—to market on September 18, 2025. Instead of the 1933 Act route, REX-Osprey leveraged a structure governed by the Investment Company Act of 1940. That framework allows a fund to become automatically effective after 75 days if regulators raise no objections, enabling a significantly faster launch timeline.

DOJE also takes a different investment approach. Rather than holding Dogecoin itself, the ETF offers synthetic exposure by allocating 80% of its assets to DOGE futures and similar derivatives, with the remaining 20% held in U.S. Treasury securities. A Cayman Islands subsidiary oversees the derivatives portion, satisfying 1940 Act standards while avoiding direct custody of crypto.

Dogecoin remains one of the most prominent digital assets, currently valued at over $23 billion and ranking as the 10th largest cryptocurrency, according to CoinGecko. Its deep liquidity and active derivatives market continue to make it attractive to ETF issuers navigating strict regulatory rules for spot-based crypto products.

Other digital assets are also gaining ETF traction. Canary Capital recently released the first spot XRP ETF, and VanEck launched a zero-fee Solana ETF to appeal to cost-focused investors. If Grayscale’s GDOG wins approval, it would further expand the range of crypto ETFs available to institutions and retail investors seeking diversified exposure to the digital-asset market.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Escalating demand for a solana ETF is accelerating sector growth as Vaneck's new launch combines cost efficiencies, staking access, and regulated structures to intensify competition and attract institutions seeking streamlined exposure to fast-execution blockchain markets.

Signet (SIG - Free Report) ended the recent trading session at $95.59, demonstrating a -5.37% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.92% for the day. Elsewhere, the Dow lost 1.18%, while the tech-heavy Nasdaq lost 0.84%.

Coming into today, shares of the jewelry company had lost 2.16% in the past month. In that same time, the Retail-Wholesale sector gained 0.48%, while the S&P 500 gained 1.48%.

The investment community will be paying close attention to the earnings performance of Signet in its upcoming release. The company is slated to reveal its earnings on December 2, 2025. The company is predicted to post an EPS of $0.16, indicating a 33.33% decline compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $1.37 billion, indicating a 1.45% increase compared to the same quarter of the previous year.

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $8.99 per share and revenue of $6.8 billion, indicating changes of +0.56% and +1.48%, respectively, compared to the previous year.

It is also important to note the recent changes to analyst estimates for Signet. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Signet is currently a Zacks Rank #3 (Hold).

Valuation is also important, so investors should note that Signet has a Forward P/E ratio of 11.24 right now. This denotes a discount relative to the industry average Forward P/E of 25.31.

One should further note that SIG currently holds a PEG ratio of 1.17. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Retail - Jewelry industry held an average PEG ratio of 4.84.

The Retail - Jewelry industry is part of the Retail-Wholesale sector. Currently, this industry holds a Zacks Industry Rank of 90, positioning it in the top 37% of all 250+ industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Helmerich & Payne (HP - Free Report) reported $1.01 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 45.8%. EPS of -$0.01 for the same period compares to $0.76 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $975.66 million, representing a surprise of +3.7%. The company delivered an EPS surprise of -103.85%, with the consensus EPS estimate being $0.26.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Helmerich & Payne performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Average active rigs - North America Solutions: 141 versus the four-analyst average estimate of 141.Average active rigs - Offshore Solutions: 3 versus 3 estimated by four analysts on average.Number of available rigs at the end of period - Offshore Solutions: 7 compared to the 7 average estimate based on four analysts.Number of available rigs at the end of period - International Solutions: 137 versus the four-analyst average estimate of 137.Number of available rigs at the end of period - North America Solutions: 223 versus 223 estimated by four analysts on average.Average active rigs - International Solutions: 62 compared to the 64 average estimate based on four analysts.Operating Revenues- North America Solutions: $572.27 million compared to the $554.59 million average estimate based on five analysts. The reported number represents a change of -7.4% year over year.Operating revenues - Offshore Solutions: $180.33 million versus the five-analyst average estimate of $161.29 million. The reported number represents a year-over-year change of +554.7%.Operating Revenues- International Solutions: $241.23 million versus $237.54 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +430.6% change.Operating Revenues- Drilling services: $990.21 million versus the two-analyst average estimate of $959.21 million. The reported number represents a year-over-year change of +43.2%.Operating Revenues- Other: $21.54 million versus the two-analyst average estimate of $3.21 million. The reported number represents a year-over-year change of +761.5%.Segment operating income (loss)- North America Solutions: $118.16 million compared to the $133.56 million average estimate based on five analysts.View all Key Company Metrics for Helmerich & Payne here>>>

Shares of Helmerich & Payne have returned +20.4% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Trip.com (TCOM - Free Report) came out with quarterly earnings of $3.87 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $1.25 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +236.52%. A quarter ago, it was expected that this travel services company would post earnings of $0.98 per share when it actually produced earnings of $1.01, delivering a surprise of +3.06%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Trip.com, which belongs to the Zacks Leisure and Recreation Services industry, posted revenues of $2.58 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.41%. This compares to year-ago revenues of $2.26 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Trip.com shares have added about 4.9% since the beginning of the year versus the S&P 500's gain of 14.5%.

What's Next for Trip.com?While Trip.com has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Trip.com was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.76 on $2.02 billion in revenues for the coming quarter and $3.69 on $8.56 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Leisure and Recreation Services is currently in the top 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Vail Resorts (MTN - Free Report) , another stock in the same industry, has yet to report results for the quarter ended October 2025.

This ski resort operator is expected to post quarterly loss of $5.23 per share in its upcoming report, which represents a year-over-year change of -13.5%. The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level.

Vail Resorts' revenues are expected to be $271.64 million, up 4.4% from the year-ago quarter.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Hormel securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=47180 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On October 29, 2025, The Wall Street Journal published an article entitled “Hormel Cuts Forecast on Price Pressure, Consumer Backdrop; Parts Ways With CFO.” The article stated that Hormel “warned earnings in the latest quarter were squeezed by price pressures, bird flu and a fire that damaged its Arkansas peanut butter production facility. The company also said it was parting ways with its top finance executive[.]”

On this news, Hormel Foods stock fell 9.1% on October 29, 2025.

 WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Dollar General (DG - Free Report) closed the most recent trading day at $103.15, moving -1.1% from the previous trading session. This change lagged the S&P 500's 0.92% loss on the day. Meanwhile, the Dow experienced a drop of 1.18%, and the technology-dominated Nasdaq saw a decrease of 0.84%.

Prior to today's trading, shares of the discount retailer had lost 1.36% lagged the Retail-Wholesale sector's gain of 0.48% and the S&P 500's gain of 1.48%.

Investors will be eagerly watching for the performance of Dollar General in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on December 4, 2025. The company's earnings per share (EPS) are projected to be $0.95, reflecting a 6.74% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $10.62 billion, up 4.25% from the prior-year quarter.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $6.13 per share and revenue of $42.5 billion. These totals would mark changes of +3.55% and +4.66%, respectively, from last year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Dollar General. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.02% higher. Dollar General presently features a Zacks Rank of #2 (Buy).

With respect to valuation, Dollar General is currently being traded at a Forward P/E ratio of 17. This represents a discount compared to its industry average Forward P/E of 25.89.

Investors should also note that DG has a PEG ratio of 2.19 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As of the close of trade yesterday, the Retail - Discount Stores industry held an average PEG ratio of 2.63.

The Retail - Discount Stores industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 67, finds itself in the top 28% echelons of all 250+ industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

In the latest trading session, FedEx (FDX - Free Report) closed at $264.73, marking a -1.06% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.92%. At the same time, the Dow lost 1.18%, and the tech-heavy Nasdaq lost 0.84%.

Shares of the package delivery company have appreciated by 12.52% over the course of the past month, outperforming the Transportation sector's gain of 1.69%, and the S&P 500's gain of 1.48%.

Investors will be eagerly watching for the performance of FedEx in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $4.02, reflecting a 0.74% decrease from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $22.87 billion, up 4.13% from the prior-year quarter.

FDX's full-year Zacks Consensus Estimates are calling for earnings of $17.97 per share and revenue of $91.86 billion. These results would represent year-over-year changes of -1.21% and +4.48%, respectively.

Investors might also notice recent changes to analyst estimates for FedEx. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.23% higher within the past month. FedEx is currently sporting a Zacks Rank of #3 (Hold).

In terms of valuation, FedEx is presently being traded at a Forward P/E ratio of 14.89. For comparison, its industry has an average Forward P/E of 14.89, which means FedEx is trading at no noticeable deviation to the group.

Investors should also note that FDX has a PEG ratio of 1.48 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Transportation - Air Freight and Cargo industry held an average PEG ratio of 2.03.

The Transportation - Air Freight and Cargo industry is part of the Transportation sector. This group has a Zacks Industry Rank of 90, putting it in the top 37% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

November 17, 2025 7:24 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the "Class Period") of the important December 29, 2025 lead plaintiff deadline.

SO WHAT: If you purchased DexCom securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the DexCom class action, go to https://rosenlegal.com/submit-form/?case_id=28133 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than December 29, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) DexCom had made material design changes to the G6 and G7 continuous glucose monitoring ("CGM") systems that were unauthorized by the U.S. Food and Drug Administration (the "FDA"); (2) the foregoing design changes rendered the G6 and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (3) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (4) Defendants downplayed the true scope and severity of the issues and health risks posed by adulterated G7 devices; (5) all the foregoing subjected DexCom to an increased risk of heightened regulatory scrutiny and enforcement action, as well as significant legal, reputational, and financial harm; and (6) as a result, defendants' public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the DexCom class action, go to https://rosenlegal.com/submit-form/?case_id=28133 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274830

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of ordinary shares, including those that sold into the Merger of Sina Corporation (NASDAQ: SINA) between October 13, 2020 and March 22, 2021, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action.

SO WHAT: If you sold Sina ordinary shares, including those that sold into the Merger, during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Sina class action, go to https://rosenlegal.com/submit-form/?case_id=45219 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants’ created a fraudulent scheme to depress the value of Sina ordinary shares to avoid paying a fair price to Sina’s shareholders in connection with the Merger. Defendants executed this scheme by misrepresenting and/or omitting material information within and from Sina’s proxy materials in connection with the Merger that were necessary for shareholders to make an informed decision concerning whether to vote in favor of the Merger. Specifically, defendants failed to disclose that: (1) defendants concealed the true value of Sina’s investment in TuSimple at the time of the Merger; (2) in turn, the offer of $43.30 per ordinary share as consideration for the Merger substantially shortchanged the true value of Sina ordinary shares; and (3) as a result, defendants’ statements about Sina’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To join the Sina class action, go to https://rosenlegal.com/submit-form/?case_id=45219 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

November 17, 2025 7:30 PM EST | Source: Cathedra Bitcoin Inc.
Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Cathedra Bitcoin Inc. (TSXV: CBIT) (OTCQB: CBTTF) ("Cathedra", the "Company", "we" or "us"), a leading developer and operator of power and digital infrastructure assets across North America, today announces its financial results for the three months ended September 30, 2025.

Highlights

Total revenue reached C$5.5 million.

The Company recorded a net loss of C$0.8 million, a reduction of C$3.2 million as compared to the same period of 2024.

Subsequent events:

Consolidation: The Company completed a 30:1 consolidation of its issued and outstanding subordinate voting shares and multiple voting shares with a record date of October 14, 2025 to streamline the Company's capital structure.

Data Center Expansion: The Company completed the construction of a new 15-megawatt (MW) data center, which effectively increased the existing power capacity by 50% across its portfolio in Kentucky, USA.

Infrastructure Development: The Company continued to advance its pipeline of high-potential sites, reinforcing its commitment to expanding its bitcoin mining and hosting infrastructure.

Management Commentary

"As we reflect on recent developments at Cathedra, the Company has hit several key milestones that underscore our commitment to operational excellence and strategic growth in the bitcoin mining and hosting sector," said Joel Block, CEO of Cathedra. "First, we successfully completed a 30:1 consolidation of our issued and outstanding subordinated and multiple voting shares to reduce the number of shares currently outstanding and streamline the Company's capital structure. Additionally, we have completed the construction of a new 15 megawatt (MW) data center on-time and under budget, which effectively increases the existing power capacity of our portfolio by 50%. Site development commenced in August 2025 and was brought online by October 2025, demonstrating our team's efficiency and dedication to rapid execution. We continue to expand our portfolio amid scarcity of power across the market and a general lack of available capacity, and we maintain a robust pipeline of greenfield opportunities in two forms: (i) bolt-on expansions at existing sites and (ii) new site development across a range of geographic regions."

Block continued, "During the quarter and after quarter-end, we have continued to restructure and rebalance our customer mix of hosting clients to optimize performance and profitability. Looking ahead, Cathedra remains committed to scaling our energy infrastructure to meet the growing demand for bitcoin mining and hosting services, while also evaluating other productive uses of our expanding power portfolio. We continue to set ourselves apart in this dynamic market by leveraging innovative power strategies across our assets to optimize efficiency and reduce costs. These developments reflect our continued focus on growing hosted infrastructure and strengthening relationships with leading industry partners."

About Cathedra

Cathedra develops and operates power and digital infrastructure assets across North America. The Company hosts bitcoin mining clients across its portfolio of four data centers (45 MW total) in Tennessee and Kentucky. Cathedra also operates a fleet of proprietary bitcoin mining machines at its own and third-party data center, producing approximately 400 PH/s of hash rate. Cathedra is headquartered in Vancouver and its subordinate voting shares trade on the TSX Venture Exchange under the symbol CBIT and in the OTC market under the symbol CBTTF.

For more information about Cathedra, visit cathedra.com or follow Company news on Twitter at @CathedraBitcoin or on Telegram at @CathedraBitcoin.

Media and Investor Relations Inquiries

Please contact:

Cautionary Statement

Trading in the securities of the Company should be considered highly speculative. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains certain "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities laws that are based on expectations, estimates and projections as at the date of this news release. The information in this release about future plans and objectives of the Company, including greenfield opportunities are forward-looking information. Forward-looking information contained in this news release includes but is not limited to information concerning general infrastructure development and other statements regarding future plans and objectives of the Company. Any statements that involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. This forward-looking information is based on reasonable assumptions and estimates of management of the Company at the time it was made. The Company has also assumed that no significant events occur outside of its normal course of business.

Additionally, these forward-looking statements may be affected by risks and uncertainties in the business of Cathedra and general market conditions. Investors are cautioned that forward-looking statements are not based on historical facts but instead reflect Cathedra's management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Cathedra believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed thereon, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are the following: an inability successfully integrate the Kungsleden business on terms which are economic or at all; a failure to realize the expected benefits of the business plan to develop and operate high-density compute infrastructure for bitcoin mining and/or other potential end markets; the risks of an increase in the Company's electricity costs, cost of natural gas, changes in currency exchange rates, energy curtailment or regulatory changes in the energy regimes in the jurisdictions in which the Company operates and the potential adverse impact on the Company's profitability; revenue may not increase as currently anticipated, or at all; it may not be possible to profitably liquidate the current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on operations; an increase in network difficulty may have a significant negative impact on operations; the volatility of digital currency prices; future capital needs and the ability to complete current and future financings, as well as capital market conditions in general; volatile securities markets impacting security pricing unrelated to operating performance; historical prices of digital currencies and the ability to mine digital currencies that will be consistent with historical prices; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws and regulations both locally and in foreign jurisdictions; compliance with extensive government regulation and the costs associated with compliance; unanticipated costs; changes in market conditions impacting the average revenue per MWh; and the risks and uncertainties associated with foreign markets. Additionally, the forward-looking statements contained herein may be affected by risks and uncertainties in the business of Cathedra and general market conditions. Please see the Company's management information circular dated June 18, 2024 which is available for view the Company's SEDAR+ profile on www.sedarplus.ca. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Readers should not place undue reliance on forward-looking information. The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274923

November 17, 2025 7:31 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Inspire Medical class action, go to https://rosenlegal.com/submit-form/?case_id=21452 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants misrepresented and failed to disclose key facts about Inspire V, a sleep apnea device, including the actual market demand for the device and whether Inspire Medical had taken the steps necessary to launch it. Defendants issued a series of materially false and misleading statements that led investors to believe that demand for Inspire V was strong and that Inspire Medical had taken the necessary steps for a successful launch. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Inspire Medical class action, go to https://rosenlegal.com/submit-form/?case_id=21452 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274883

November 17, 2025 7:35 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of James Hardie Industries plc (NYSE: JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the "Class Period") of the important December 23, 2025 lead plaintiff deadline.

SO WHAT: If you purchased James Hardie common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the James Hardie class action, go to https://rosenlegal.com/submit-form/?case_id=46976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 23, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, James Hardie Industries plc misled investors about the strength of its key North America Fiber Cement segment between May 20 and August 18, 2025. Despite knowing by April and early May that distributors were destocking inventory, James Hardie falsely claimed demand remained strong and that stock levels were "normal." When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the James Hardie class action, go to https://rosenlegal.com/submit-form/?case_id=46976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274840

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline.

So what: If you purchased Cytokinetics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Cytokinetics class action, go to https://rosenlegal.com/submit-form/?case_id=45298 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 17, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements regarding the timeline for the New Drug Application ("NDA") submission and approval process for aficamten. Specifically, defendants represented that Cytokinetics expected approval from the U.S. Food and Drug Administration ("FDA") for its NDA for aficamten in the second half of 2025, based on a September 26, 2025 Prescription Drug User Fee Act ("PDUFA") date, and failed to disclose material risks related to Cytokinetics' failure to submit a Risk Evaluation and Mitigation Strategy ("REMS") that could delay the regulatory process. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Cytokinetics class action, go to https://rosenlegal.com/submit-form/?case_id=45298 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Franklin Templeton has named Coinbase Custody as the custodian for its proposed spot XRP exchange-traded fund, according to the final prospectus submitted to the U.S. Securities and Exchange Commission. The asset manager, which manages about $1.6 trillion, disclosed that the product is scheduled to begin trading on November 18 once regulatory conditions are met.

In brief
Hive Digital Technologies stock rose about 7.5% on Monday.
The Bitcoin miner reported record revenue in its fiscal Q2 earnings, up 285% year-over-year.
Hive's Buzz subsidiary also revealed a deal with Dell for GPUs to fuel its high-performance computing business.
Publicly traded Bitcoin mining firm Hive Digital Technologies’ stock climbed Monday following the announcement of record revenue last quarter, along with a deal with computer maker Dell to power the expanding AI ambitions of Hive’s subsidiary.

Hive reported second-quarter fiscal year results ending September 30, achieving record revenue of $87.3 million—a vast 285% year-over-year increase, and 91% rise compared to the previous quarter. The company reported adjusted EBITDA of $31.5 million, pointing to strong results across both its Bitcoin mining and high-performance computing (HPC) segments.

Hive’s stock was on the rise Monday, jumping by more than 7.5% to a closing price of $3.56. Hive bucked the daily trend, which saw many major crypto stocks fall—including Circle (CRCL) by more than 6% and Coinbase (COIN) by about 7%.

Despite the daily rise, HIVE is down by more than 37% over the last month, echoing losses weathered by other prominent crypto stocks amid falling asset prices in recent weeks.

Hive climbed even as Bitcoin continued falling Monday, with the price of the top crypto asset dipping below the $92,000 mark for the first time since April. Bitcoin has now erased all of its 2025 gains, and has fallen by 27% since setting a new all-time high price above $126,000 in early October.

Hive’s Bitcoin mining revenue reached $82.1 million, driven by an 86% quarter-over-quarter increase in average hash rate to 16.2 EH/s. HIVE mined 717 Bitcoin during the quarter, up 77% from Q1 despite increased network difficulty.

Meanwhile, Hive’s Buzz high-performance computing division generated record revenue of $5.2 million, up 175% year-over-year. Gross operating margins improved significantly to 49%, though GAAP net loss was $15.8 million due to accelerated depreciation of Hive’s Bitcoin mining rigs.

Hive said it completed a 300 MW addition of new capacity in Paraguay, and recently achieved 25 EH/s operational hash rate. The company now operates a global hydro-powered data center footprint of 540 MW, with a secured path to 400 MW in Paraguay through power purchase agreements. Management projects potential scaling to 35 EH/s by Q4 2026.

Alongside earnings, Hive’s Buzz subsidiary announced a deal with Dell Technologies to deploy 504 of the manufacturer’s latest-generation GPUs through liquid-cooled servers at the Bell AI Fabric data center. The company is targeting a fleet exceeding 6,000 new GPUs by the end of 2026, paired with 5,000 GPUs that are already operational.

This expansion is projected to generate approximately $140 million in annualized HPC revenue by Q4 2026 at roughly 80% gross margins.

Many Bitcoin miners have embraced the high-performance computing opportunity amid the AI boom, and at least one, Bitfarms, recently said it will “wind down” its crypto business entirely. But Hive said it believes it has an advantage over miners that are just now entering the HPC space.

“We know a lot about Bitcoin mining, and we also know in depth and breadth more than these other Bitcoin miners that are going into the space of AI,” said Hive Executive Chairman Frank Holmes in Monday’s earnings call. “We've been doing it for three years. I believe we're quite successful. It's much more complicated.”

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

The much-anticipated public offering of Monad's native token via Coinbase generated about $43 million within the first half hour.

Cboe Global Markets is preparing to introduce a new class of crypto derivatives that could reshape how U.S. traders gain long-term exposure to digital assets. Beginning Dec. 15, the exchange will debut Bitcoin Continuous Futures (PBT) and Ether Continuous Futures (PET), marking the first time a U.S. exchange offers crypto products designed to function similarly to perpetual futures commonly found on offshore platforms.

These new contracts aim to meet surging demand for tools that allow traders to maintain ongoing, leveraged crypto positions without the inconvenience of rolling expiring futures. Each product will launch with a 10-year expiration and will settle in cash, giving institutional and sophisticated retail traders a regulatory-compliant alternative to offshore perpetual futures markets. By using daily funding adjustments tied to the Cboe Kaiko Real-Time Rate for bitcoin and ether, the contracts are engineered to stay closely aligned with spot market prices while offering a familiar funding mechanism similar to perpetual futures.

Cboe first teased the concept in September, presenting it as a response to the growing popularity of perpetual futures in the crypto world—despite their limited presence in traditional finance. While many offshore platforms dominate the perpetual futures market, Cboe’s version is built to satisfy U.S. regulatory standards, with clearing handled through Cboe Clear U.S., a CFTC-regulated clearinghouse. According to Rob Hocking, Cboe’s global head of derivatives, the structure is designed to streamline risk management and offer traders a more controlled method of accessing leveraged digital asset exposure.

The new contracts will support long and short positions, margin trading and the possibility of cross-margining with existing Cboe crypto futures, such as FBT and FET. This could make them particularly attractive to hedge funds, asset managers and traders seeking a safer, regulation-friendly alternative to offshore platforms. Trading will operate nearly 24/5, from Sunday evening to Friday evening Eastern Time, enabling almost round-the-clock market access.

These continuous futures could become a significant milestone in bridging traditional finance and crypto derivatives, offering institutional-grade security with the flexibility crypto traders expect.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Fundstrat's and CNBC Contributor Tom Lee tells CNBC's Leslie Picker on “ETF Edge” he believes the market is ‘nearing a bottom.' Bitwise Asset Management CIO Matt Hougan agrees, saying there are ‘great buying opportunities for long-term investors.

Journalist

Posted: November 18, 2025

Key Takeaways
How much has XRP declined from its recent high?
XRP has dropped 16.17% from its recent peak at $2.60, currently trading at $2.1551, with a 2.62% decline as of 17 November.

What percentage of XRP holders are now in loss?
Approximately 30-35% of XRP supply is currently held at a loss according to Glassnode data, marking a significant deterioration from October.

XRP continues its downward trajectory despite the historic launch of spot XRP ETFs on 14 November, with the token declining 16% from recent highs as holder profitability collapses to levels not seen since earlier this year.

The cryptocurrency trades at $2.1551 as of this writing, extending losses from the $2.60 level reached in recent weeks. 

The 16.17% decline occurred despite regulatory clarity improving through the launch of its spot XRP ETF in September, which marked the first U.S.-listed fund offering direct exposure to the asset.

Holder profitability collapses to multi-month lows
Glassnode data reveals a dramatic deterioration in XRP holder profitability throughout November. 

The percent of supply in profit has crashed from approximately 85-90% in October to current levels between 65-70%, meaning roughly one-third of all XRP holders now sit on unrealized losses.

Source: Glassnode

This marks a significant shift from earlier periods when nearly 100% of supply remained profitable. During January’s rally to $4 and again in July and August, when XRP traded near $3.50, virtually all holders enjoyed gains. 

The current reading represents the lowest profitability level since November 2024.

The correlation between declining prices and supply profitability demonstrates mounting pressure on holders. 

As more wallets fall underwater, the risk of capitulation selling increases, potentially accelerating downward momentum if support levels fail to hold.

XRP technical indicators signal ongoing weakness
XRP’s Relative Strength Index stands at 37.81, indicating oversold conditions are approaching but have not yet been reached. 

The indicator suggests additional downside remains possible before a technical bounce materializes. 

Source: TradingView

Previous RSI readings below 30 historically marked short-term bottoms, though current momentum shows no signs of reversal.

Price action reveals failed attempts to sustain rallies above $2.60. Each bounce has met immediate selling pressure, pushing XRP back toward the $2.10-$2.15 support zone. 

A breakdown below this level could accelerate losses toward the $2.00 psychological barrier.

The decline proves particularly notable given the timing. XRP ETFs launched in the previous week amid expectations that regulated investment products would drive institutional demand. 

Market context and ETF impact
Despite these institutional developments, XRP has failed to maintain momentum. The token peaked near $3.40 during the earlier 2025 rallies but has since surrendered most of its gains. 

Current prices sit approximately 37% below those highs, with the recent 16% decline from $2.60 representing fresh weakness.

The broader cryptocurrency market’s weakness has contributed to XRP’s decline. Bitcoin and Ethereum both face selling pressure, with Bitcoin testing $92,000 support and Ethereum briefly breaking below $3,000. 

This sector-wide correction has weighed on altcoins, including XRP, regardless of individual fundamental developments.

A sharp divergence emerged in the crypto ETF market this month.

According to SoSo Value data, the new products tracking Solana and XRP are attracting significant capital, contrasting with a severe wave of outflows from established Bitcoin and Ethereum funds.

The data shows that the newly launched altcoin ETFs have registered more than $500 million in combined inflows in less than a month.

These inflows highlight growing investor interest in assets beyond the market leaders.

Solana ETFs, which launched in October, have accumulated $382.05 million in total inflows in just three weeks. The three funds, managed by Grayscale, Bitwise, and VanEck, now oversee combined assets worth more than $541.31 million, according to SoSo Value.

Meanwhile, demand for the newer XRP product has proven similarly robust.

The spot XRP ETF, launched by Canary Capital last week, attracted $250 million in its first day of trading on nearly $60 million in volume.

Nate Geraci, co-founder of the ETF Institute and President of NovaDius Wealth, highlighted the significance of the product’s performance on X, saying:

“Canary XRP ETF has [posted the] highest day one trading volume out of 900+ ETF launches this year.”

According to him, this was further evidence of how spot crypto ETFs’ performance has consistently and significantly surpassed the expectations of the traditional finance sector.

While he noted that skepticism from the “old guard” of traditional finance remains high, investor capital is the definitive measure of success.

Still, he pointed out that spot crypto ETFs have consistently exceeded expectations and have come to dominate the list of top ETF launches in the last two years.

Bitcoin and Ethereum see major outflowsThe enthusiasm for altcoin funds stands in stark contrast to US-based spot Bitcoin ETFs, which recorded significant outflows of more than $3 billion over the three weeks ending Nov. 14.

The redemptions were sustained, beginning with $798 million for the week ending Oct. 31. Outflows then accelerated to $1.2 billion for the week ending Nov. 7, followed by another $1.1 billion shed for the week ending Nov. 14.

US Bitcoin ETF Flows (Source: Trader T)Ethereum ETFs experienced a similar trend, shedding more than $1.2 billion in total during the same period. Following modest inflows of $15 million in the last week of October, the ETH funds experienced significant outflows of more than $500 million and $728 million in the subsequent two weeks.

US Spot Ethereum ETFs Flows (Source: Trader T)That amounts to a total of $4.2 billion in outflows across Bitcoin and Ethereum ETFs alone.

James Butterfill of CoinShares suggested the recent drawdowns from the Bitcoin and Ethereum ETFs are linked to macro-level concerns.

He wrote:

“We believe the combination of monetary policy uncertainty and crypto-native whale sellers are the main reasons for this most recent negative funk.”

Meanwhile, BlackRock’s funds were responsible for around 50% of the redemptions, with IBIT and ETHA collectively losing more than $2 billion. Nearly $1.4 billion left IBIT, while over $700 million exited ETHA.

During this period, BlackRock’s ETHA registered a $421 million outflow, its largest weekly loss since launching in 2024.

Despite the recent pullback, a Q3 2025 overview of IBIT’s institutional ownership showed a 15% increase in the number of institutional holders. Total institutional ownership rose by 1% to reach 29%, with Sovereign Wealth Fund and UAE ownership at 2.14% and 4.1%, respectively.

Mentioned in this article

November 17, 2025 5:26 PM EST | Source: Radisson Mining Resources
Rouyn-Noranda, Quebec--(Newsfile Corp. - November 17, 2025) - Radisson Mining Resources Inc. (TSXV: RDS) (OTCQX: RMRDF) ("Radisson" or the "Company") is pleased to announce that it has received total gross proceeds of C$1,481,694.12 from the exercise of 5,487,756 class A shares purchase warrants (the "Warrants") at a price of $0.27 per warrant. The Warrants were issued in relation to a private placement completed in November 2023 and had an expiry of November 17, 2025.

Furthermore, the Company has received additional total gross proceeds of C$42,126.72 from the early exercise of 113,856 class A shares purchase warrants (the "Warrants") at a price of $0.37 per warrant. The warrants were issued in relation to a private placement completed in October 2024.

Matt Manson, President and CEO, commented: "The exercise of these warrants, held by long-standing and supportive shareholders, further strengthens Radisson's financial position and supports the Company's ongoing growth initiatives. At the end of October, our treasury stood at approximately C$36 million, fully funding our ongoing 140,000 metre step out drill program at the O'Brien Gold Project."

As of today, 5,430,431 warrants remain outstanding at an exercise price of $0.37, with expiry dates ranging from October 22, 2026, to October 29, 2026. If fully exercised, these warrants represent potential gross proceeds of C$2,009,259.47. No warrants were issued in connection with the Company's C$12 million private placement, completed in May 2025, nor in the most recent C$25 million private placement, completed in October 2025.

Radisson Mining Resources Inc.

Radisson is a gold exploration company focused on its 100% owned O'Brien Gold Project, located in the Bousquet-Cadillac mining camp along the world-renowned Larder-Lake-Cadillac Break in Abitibi, Québec. A July 2025 Preliminary Economic Assessment described a low cost and high value project with an 11-year mine life and significant upside potential based on the use of existing regional infrastructure. Indicated Mineral Resources are estimated at 0.58 million ounces (2.20 million tonnes at 8.2 g/t Au), with additional Inferred Mineral Resources estimated at 0.93 million ounces (6.67 million tonnes at 4.4 g/t Au). Please see the NI 43-101 "O'Brien Gold Project Technical Report and Preliminary Economic Assessment, Québec, Canada" effective June 27, 2025, and other filings made with Canadian securities regulatory authorities available at www.sedarplus.ca for further details and assumptions relating to the O'Brien Gold Project.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of the applicable Canadian securities legislation that is based on expectations, estimates, projections, and interpretations as at the date of this news release. Forward-looking statements including, but are not limited to, statements with respect to the ability to execute the Company's plans relating to the O'Brien Gold Project as set out in the Preliminary Economic Assessment; the Company's ability to complete its planned exploration and development programs; the absence of adverse conditions at the O'Brien Gold Project; the absence of unforeseen operational delays; the absence of material delays in obtaining necessary permits; the price of gold remaining at levels that render the O'Brien Gold Project profitable; the Company's ability to continue raising necessary capital to finance its operations; the ability to realize on the mineral resource and mineral reserve estimates; assumptions regarding present and future business strategies; local and global geopolitical and economic conditions and the environment in which the Company operates and will operate in the future; planned and ongoing drilling; the significance of drill results; the ability to continue drilling; the impact of drilling on the definition of any resource; and the ability to incorporate new drilling in an updated technical report and resource modelling; the Company's ability to grow the O'Brien Gold Project; and the ability to convert inferred mineral resources to indicated mineral resources.

Any statement that involves discussions with respect to predictions, expectations, interpretations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "interpreted", "management's view", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. Except for statements of historical fact relating to the Company, certain information contained herein constitutes forward-looking statements Forward-looking information is based on estimates of management of the Company, at the time it was made, involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the companies to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Such factors include, among others; the risk that the O'Brien Gold Project will never reach the production stage (including due to a lack of financing); the Company's capital requirements and access to funding; changes in legislation, regulations and accounting standards to which the Company is subject, including environmental, health and safety standards, and the impact of such legislation, regulations and standards on the Company's activities; price volatility and availability of commodities; instability in the global financial system; the effects of high inflation, such as higher commodity prices; the risk of any future litigation against the Company; changes in project parameters and/or economic assessments as plans continue to be refined; the risk that actual costs may exceed estimated costs; geological, mining and exploration technical problems; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; risks relating to the drill results at O'Brien; the significance of drill results; and the ability of drill results to accurately predict mineralization. Although the forward-looking information contained in this news release is based upon what management believes, or believed at the time, to be reasonable assumptions, the parties cannot assure shareholders and prospective purchasers of securities that actual results will be consistent with such forward-looking information, as there may be other factors that cause results not to be as anticipated, estimated or intended, and neither the Company nor any other person assumes responsibility for the accuracy and completeness of any such forward-looking information. The Company believes that this forward-looking information is based on reasonable assumptions, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this press release should not be unduly relied upon. The Company does not undertake, and assumes no obligation, to update or revise any such forward-looking statements or forward-looking information contained herein to reflect new events or circumstances, except as may be required by law. These statements speak only as of the date of this news release.

Please refer to the "Risks and Uncertainties Related to Exploration" and the "Risks Related to Financing and Development" sections of the Company's Management's Discussion and Analysis dated April 29, 2025 for the year ended December 31, 2024, and the Company's Management's Discussion and Analysis dated August 27, 2025 for the three-month period ended June 30, 2025, all of which are available electronically on SEDAR+ at www.sedarplus.ca. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274899

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2026 Earnings Call November 17, 2025 11:30 AM EST

Company Participants

Nasrat Hakim - Chairman, CEO & President
Carter Ward - CFO, Secretary & Treasurer

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of Fiscal Year 2026 Conference Call. [Operator Instructions]

Before management begins speaking, the conference has the following statement. Elite would like to remind the listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties that are subject to change at any time, including, but not limited to, statement about Elite's expectations regarding forward operating results. Forward-looking statements are made pursuant to the safe harbor provisions of the federal securities laws and represent management's current expectations. Actual results may differ materially. Elite disclaims any obligation to update or revise its forward-looking statements, except as required by law. More complete information regarding forward-looking statements, risks and uncertainties can be found in the reports Elite files with the SEC, which is available on Elite's website at elitepharma.com under the Investor Relations section. Elite encourages you to review these documents carefully.

With that covered, it is now my pleasure to turn the floor over to your host, Mr. Nasrat Hakim, President and Chief Executive Officer of Elite Pharmaceuticals. Sir, the floor is yours.

Nasrat Hakim
Chairman, CEO & President

Thank you, Matthew, and good morning, ladies and gentlemen, and thank you for joining us today. My name is Nasrat Hakim. I am Elite's Chairman and CEO, and this is our earnings call. Our CFO, Carter Ward, will give you a summary of the company's financials, after which I'll give you an update and answer some of the questions you've submitted to Dianne. Carter, you are on.

Carter Ward
CFO, Secretary & Treasurer

Thank

Recommended For You